Alkaline phosphatase histochemistry and biochemistry in the diagnosis of complete hydatidiform mole

Abstract

The purpose of this study was a complementary method to the diagnosis and prognosis of complete hydatidiform mole (CHM) and differentiate it from the other cases of gestational trophoblatic diseases. This was done by examining the quality and quantity of the total and the placental alkaline phosphatase activity. The ALP in the tissues and sera from 12 patients were compared with 13 control normal non-pregnant and 30 control pregnant females. The enzyme activities were determined by biochemical and histochemical examination.The placental tissues were obtained from uterine curettage, or after delivery which then were frozen in a liquid nitrogen and processed for biochemical study. Cryosections were histochemically stained for ALP and PLAP by the azo coupling method. Isoenzyme specificity was evaluated by heating the tissue at 65°C for 15 min while the including L-phenylalanine (50 mM), D-phenylalanine (50 mM) and L-homoarginine (50 mM) were used for chemical inhibition study. The activity of ALP and PLAP of patients were reduced in comparison with pregnant control group (P<0.05). There was no significant difference between the patients and non-pregnant control (P<0.05) group. The localization of enzyme activities in cryosections of all groups were in the basal, apical, and the cytoplasm of syncytiotrophoblast cells. The ALP in all the groups was thermostable (65°C for 15 min) and was inhibited by L-phenylalanine, but no inhibition was seen with L-homoarginine in patients group only. These findings suggest that the PLAP is a useful marker in the diagnosis and prognosis of hydatidiform mole.

This is a preview of subscription content, access via your institution.

Abbreviations

HM:

Hydatidiform mole

CHM:

complete hydatidiform mole

GTD:

Gestational trophoblastic disease

ALP:

Alkaline phosphatase

PLAP:

Placental alkaline phosphatase

L-ph:

L - phenylalanine

D - ph:

D -phenylalanine

L - homo:

L - homoarginine

hCG:

human chorionic gonadotropin

M:

mol

mM:

milli mol

u/mg:

unit per milligram

mg:

milligram

H & E:

Hematoxylin and Eosin stain

References

  1. 1.2

    Beckstead JH: Alkaline phosphatase histochemistry in human germ cell neoplasms. AM J Surg Pathol 7:341–349, 1983.

    PubMed  CAS  Article  Google Scholar 

  2. 2.2

    Bracken MB: Incidence and aetiology of hydatidiform mole: an epidemiological review. Br J Obstet Gynaecol 94:1123–1135, 1987.

    PubMed  CAS  Google Scholar 

  3. 3.2

    Buckley JD. The epidemiology of molar pregnancy and choriocarinoma. Clin Obstet Gynecol 27:153, 1984.

    PubMed  Article  CAS  Google Scholar 

  4. 4.2

    Bur GE, Hertig AT, F.A.C.O.G,et al: Histochemical aspects of hydatidiform mole and choriocarcinoma. Obstet Gynecol 19:156–181, 1962.

    PubMed  CAS  Google Scholar 

  5. 5.2

    Byers DA, Fernley HN, Walker PG: Studies on alkaline phosphatase inhibition of human placental phosphoryl phosphatase by L phenyl alanine. Eur J Biochem 29:197–204, 1972.

    PubMed  Article  CAS  Google Scholar 

  6. 6.2

    Cadeau MJ, Malkin A: Relative heat stability for the identification of serum alkaline phosphatase isoenzymes. Clin Chim Acta 45:235–242, 1973.

    PubMed  Article  CAS  Google Scholar 

  7. 7.2

    Chase JS, Check JH, Nowroozi KH, Wu CH: First trimester serum levels of the-subunit of human chorionic gonadotropin in a tubal molar pregnancy. Am J Obstet Gynecol 157:910, 1987.

    PubMed  CAS  Google Scholar 

  8. 8.

    Cheah PL, Looi LM. Expression of placental proteins in complete and partial hydatidiform moles. Pathol26: 115–118, 1994.

    Article  CAS  Google Scholar 

  9. 9.

    Check JH., Nowroozi KH, Chase JS, et al. False —positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay. Am J Obstet Gynecol 158: 99–100, 1988.

    PubMed  CAS  Google Scholar 

  10. 10.2

    Danithel L, Porubsky J, Vojtassak J, et al: Trophoblastic disease I. Use of imunohistochemistry in the diagnosis of complete hydatidiform moles. Cesk patol 30:76–79, 1994.

    Google Scholar 

  11. 11.2

    Danihel L, Porubsky J, Vojtassak J, et al: Trophoblastic disease II. Immunohistochemical and cytogenetic parameters of partial hydatidiform moles. Cesk Patol 30:80–84, 1994.

    PubMed  CAS  Google Scholar 

  12. 12.2

    Fukunaga M, Migazawa Y, Sugisbita M, et al: Immunohistochemistry of molar and non-molar placentas with special reference to their differenial diagnosis. Acta Pathol Jpn 43:683–689, 1993.

    PubMed  CAS  Google Scholar 

  13. 13.2

    Grimes DA: Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol 150:309–318, 1984.

    PubMed  CAS  Google Scholar 

  14. 14.2

    Ilancheran A, Singh P, Sen DK, et al: Up date on chemotherapy of gestational trophoblastic disease. Singapore J Obstet Gynecol 19:53–60, 1988.

    Google Scholar 

  15. 15.2

    Kaldor G: Clinical enzymology New York: Prager publisher 87–112, 1983.

    Google Scholar 

  16. 16.2

    Koid O, Iwai S, Kanno T, et al: Isoenzymes of alkaline phosphatase in germinoma cells. Am J Clin Pathol 89:611–616, 1988.

    Google Scholar 

  17. 17.2

    Lin CW, Fishman WH: L —homoarginine, an organospecific, uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem 247:3082–3087, 1972.

    PubMed  CAS  Google Scholar 

  18. 18.2

    Losch A, Kainz C: Immunohistochemistry in the diagnosis of the gestational trophoblatic disease. Acta Obstet Gynecol Scand 75:753–756, 1996.

    PubMed  Article  CAS  Google Scholar 

  19. 19.2

    Mckay DG, Hertig AT, Adams EC, et al: Histochemical observations on the germ cells of human embryos. Anat Rec 117: 201–219, 1953.

    PubMed  Article  CAS  Google Scholar 

  20. 20.2

    Mc Laughlin PJ Gee H, Johnson PM: Placental —type alkaline phosphatase in pregnancy and malignancy plasma: specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay. Clinica Chimica Acta 130:199–209, 1983.

    Article  CAS  Google Scholar 

  21. 21.2

    Ming Chu T: Biochemical Markers for cancer. Clinical and biochemical analysis; 11, New York: Marcel Dekker, INC publisher 93–115, 1982.

    Google Scholar 

  22. 22.2

    Ozturk M, Berkowitz R, Goldstein O, et al. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol 158:193–198, 1988.

    PubMed  CAS  Google Scholar 

  23. 23.2

    Sabellek WM: Alkaline phosphatase, laboratory and clinical Implications. J Chromato 429:419–444, 1988.

    Article  Google Scholar 

  24. 24.2

    Smith DBO Reilly SM, Newland FS: Current approaches to diagnosis and treatment of gestational trophoblastic disease. Curr Opin Obstet Gynecol 5:84–91, 1993.

    PubMed  CAS  Google Scholar 

  25. 25.2

    Sonnenwright AC, Jarett L: Gradwohl’s Clinical laboratory methods and diagnosis. 8th ed London: C.V. Mosby Co. 256–271, 1980.

    Google Scholar 

  26. 26.2

    Wang TH, Wag HS: Gestational trophoblastic diseases: Current trends and perspectives. J Formos Med Assoc 94: 449–457, 1995

    PubMed  CAS  Google Scholar 

  27. 27.2

    Yusoff Dawood M, Facog, Saxena BB, et al: Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma. Obstet Gynecol 50:172–180, 1977.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Mogdeh Salehnia.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Salehnia, M., Farzad, T.R., Tachikhani, M. et al. Alkaline phosphatase histochemistry and biochemistry in the diagnosis of complete hydatidiform mole. Pathol. Oncol. Res. 6, 105–110 (2000). https://doi.org/10.1007/BF03032358

Download citation

Keywords

  • alkaline phosphatase
  • placental alkaline phosphatase
  • complete hydatidiform mole
  • gestational trophoblastic disease